Search Results - "Lobato, Maria Inês R."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy by Silva, Eliane D., Fighera, Tayane M., Allgayer, Roberta M., Lobato, Maria Inês R., Spritzer, Poli Mara

    Published in Frontiers in psychiatry (26-07-2021)
    “…Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the sex assigned at birth and the gender identity,…”
    Get full text
    Journal Article
  2. 2

    Perceived Parenting Styles of Individuals With Gender Dysphoria by Garcia, Cláudia C., Schwarz, Karine, Costa, Angelo B., Bridi Filho, Cesar A., Lobato, Maria Inês R.

    Published in Frontiers in psychology (11-11-2021)
    “…Objective: To map patterns of behavior of parents and/or caregivers as perceived by their adult children, transgender patients seen through the Programa…”
    Get full text
    Journal Article
  3. 3

    Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors by Zortea, Karine, Franco, Viviane C, Francesconi, Lenise P, Cereser, Keila M M, Lobato, Maria Inês R, Belmonte-de-Abreu, Paulo S

    Published in Nutrients (29-01-2016)
    “…Patients with schizophrenia (SZ) are generally overweight or obese and have several metabolic disorders. Additionally, such patients have a lower life…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Risk of neutropenia among clozapine users and non-users: results from 5,847 patients by Goldani, André Akira Sueno, Rabelo-da-Ponte, Francisco Diego, Feiten, Jacson Gabriel, Lobato, Maria Ines R, Belmonte-de-Abreu, Paulo S, Gama, Clarissa S

    Published in Revista brasileira de psiquiatria (01-01-2022)
    “…Clozapine is underprescribed due to neutropenia risk. Blood tests every 3 months in those on continuous treatment for > 1 year who have never had an absolute…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Risk of neutropenia among clozapine users and non-users: results from 5,847 patients by Goldani, André Akira Sueno, Rabelo-da-Ponte, Francisco Diego, Feiten, Jacson Gabriel, Lobato, Maria Ines R., Belmonte-de-Abreu, Paulo S., Gama, Clarissa S.

    Published in Revista brasileira de psiquiatria (01-02-2022)
    “…Objective: Clozapine is underprescribed due to neutropenia risk. Blood tests every 3 months in those on continuous treatment for > 1 year who have never had an…”
    Get full text
    Journal Article